Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.-论文-万方医学网

作者： Rajesh,Balkrishnan ^[1] ; Bhakti V,Arondekar ; Fabian T,Camacho ; Rahul A,Shenolikar ; Ruslan,Horblyuk ; Roger T,Anderson

作者单位： Department of Pharmacy Practice and Administration, The Ohio State University, College of Pharmacy and School of Public Health, Columbus, Ohio 43210, USA. balkrishnan.1@osu.edu ^[1]

主题词成年人(Adult);糖尿病, 2型(Diabetes Mellitus, Type 2);急诊室, 医院(Emergency Service, Hospital);女(雌)性(Female);卫生保健调查(Health Care Surveys);卫生服务(Health Services);住院(Hospitalization);人类(Humans);降血糖药(Hypoglycemic Agents);线性模型(Linear Models);男(雄)性(Male);Medicaid(Medicaid);中年人(Middle Aged);多元分析(Multivariate Analysis);北卡罗来纳(North Carolina);病人依从(Patient Compliance);回顾性研究(Retrospective Studies);噻唑烷二酮类(Thiazolidinediones);时间因素(Time Factors);治疗结果(Treatment Outcome)

PMID 18046930

发布时间 2018-12-01

检索历史清除

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.

Clinical therapeutics

相似文献

Clinical therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in medicaid-enrolled patients with type 2 diabetes mellitus.

Clinical therapeutics

相似文献

Clinical therapeutics

相关期刊

检索历史清除